Opko - M&A Summary and Business Overview

Life ScienceCompany

Opko M&A Summary

Opko has acquired 20 companies, including 1 in the last 5 years. It has also divested 3 assets.

Opko’s largest acquisition to date was in 2015, when it acquired Bio-Reference Laboratories for $1.5B. It’s largest disclosed sale occurred in 2021, when it sold OPKO Health - Sterile Fill & Finish Manufacturing Facility to Horizon Therapeutics Public Limited Company for $65M. Opko has acquired in 5 different US states, and 9 countries. The Company’s most targeted sectors include medical products (50%) and life science (45%).

Opko Business Overview

Where is Opko headquartered?

Opko is headquartered in Miami, Florida.

What is Opko’s revenue?

Opko disclosed revenue of 713M USD for 2024 and 863M USD for 2023.

How many employees does Opko have?

Opko has 2,997 employees.

What sector is Opko in?

Opko is a life science company.

When was Opko founded?

Opko was founded in 1991.

M&A Summary

  • M&A Total Activity23
    • M&A Buy Activity20
    • M&A Sell Activity3
  • Total Sectors Invested 3
  • Total Countries Invested 9
  • M&A Buy/Sell Connections 4
  • M&A Advisors 4

Opko

Opko Health, Inc.

4400 Biscayne Boulevard,
Miami, Florida 33137
United States,
(305) 575-4100
www.opko.com

Opko is a diversified healthcare company with a focus on establishing leading positions in significant and rapidly growing medical markets. Opko's operations are divided into diagnostics and pharmaceuticals, each with specialized products and services aimed at improving patient care and outcomes. Opko was founded in 1991 and is based in Miami, Florida.


M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.2/yr) # 19 - 1 - - - 20
vol $2.0B $300M $2.3B
Sell (0.2/yr) # 2 1 - - - - 3
vol $65M $65M
  23

Most Recent M&A

Company Date Value Type
ModeX Therapeutics, Inc. 2022-05-09 300M USD Add-on Acquisition
Natick, Massachusetts · www.modextherapeutics.com
OPKO Health - Sterile Fill & Finish Manufacturing Facility 2021-06-17 65M USD Divestiture
Waterford, Ireland
CareEvolve 2017-02-17 - Divestiture
Elmwood Park, New Jersey · www.careevolve.com
Transition Therapeutics, Inc. 2016-06-30 60M USD Add-on Acquisition
Toronto, Ontario · www.transitiontherapeutics.com
Bio-Reference Laboratories, Inc. 2015-08-20 1.5B USD Add-on Acquisition
Elmwood Park, New Jersey · www.bioreference.com
EirGen Pharma Ltd. 2015-05-05 - Add-on Acquisition
Waterford, Ireland
Inspiro Medical Ltd. 2014-05-22 - Add-on Acquisition
Misgav, Israel · www.inspiromedical.com
Laboratorio Arama de Uruguay Limitada 2014-01-08 - Add-on Acquisition
Montevideo, Uruguay
PROLOR Biotech, Inc. 2013-08-29 480M USD Merger
Nes Ziyyona, Israel · www.prolor-biotech.com
Cytochroma, Inc. 2013-03-04 - Add-on Acquisition
Markham, Ontario · www.cytochroma.com
View All >>

Business Unit M&A

Company Acquired Add-On/Sale Date #
Bio-Reference Laboratories, Inc. 2015-08-20 GeneDx, Inc. 2022-01-18 1
Elmwood Park, New Jersey · www.bioreference.com Gaithersburg, Maryland · www.genedx.com
Bio-Reference Laboratories, Inc. 2015-08-20 Roche Holding - U.S. Ariosa Centralized Laboratory Prenatal Testing Business 2021-08-16 1
Elmwood Park, New Jersey · www.bioreference.com Elmwood Park, New Jersey

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 9 (45%) 2.3B (99%) 2 (67%) 65M (100%)
Medical Products 10 (50%) 16M (1%) - -
Distribution 1 (5%) 4M (< 1%) - -
Internet Software and Services - - 1 (33%) -
Total 20 $2.3B 3 $65M

By Geo

State/Country Buy Value Sell Value
United States 7 1.8B 2 -
  Massachusetts 2 300M - -
  New Jersey 1 1.5B 1 -
  Tennessee 1 - - -
  Florida 1 - - -
Canada 3 60M - -
  Ontario 3 60M - -
Israel 3 480M - -
Chile 2 20M - -
Ireland 1 - 1 65M
Brazil 1 - - -
Mexico 1 - - -
Spain 1 - - -
Uruguay 1 - - -
Domestic 7 (35%) 1.8B (76%) 2 (67%) -
Cross-border 13 (65%) 560M (24%) 1 (33%) 65M (100%)
Total 20 $2.3B 3 $65M

Top M&A Advisors

Financial Deals
J.P. Morgan Securities
1
Barrington Research Associates
1
Legal Deals
Akerman
1
GreenbergTraurig
1

Deal Values

buy # Total
> $1B 1 $1.5B
$100M to $1B 2 $780M
< $100M 3 $80M
TOTAL $2.3B
Largest Bio-Reference Laboratories, Inc.
$1.5B (2015-08-20)
sell # Total
< $100M 1 $65M
TOTAL $65M
Largest OPKO Health - Sterile Fill & Finish Manufacturing Facility
$65M (2021-06-17)

M&A Connections

Deals
Acquired from
Strategic(s)
5%
1 (5%)
Divested to
Strategic(s)
100%
3 (100%)

 Subscribe to unlock this and 214,646
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore a company's M&A activity, ownership history, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for Opko

Life Science Companies